Development of a Novel Bio-Adhesive Mesh System for Abdominal Hernia Repair Project Summary/Abstract This project proposes the development of a novel mesh-adhesive system for abdominal hernia repair utilizing surface modification of polymer surgical mesh to allow for improved tissue fixation with a poloxamine hydrogel adhesive. More than 1 million Americans undergo hernia repair with surgical mesh each year, most commonly with polypropylene (PP) mesh, with associated annual healthcare costs in excess of $3 billion. During abdominal hernia repair, a majority of surgical meshes are fixed to abdominal tissue by mechanical devices (e.g. sutures, staples, tacks) or tissue adhesives (e.g. fibrin sealant, cyanoacrylate-based glue). Mechanical devices are difficult to employ laparoscopically and can cause substantial post-operative pain. As such, fixation with tissue adhesives has been attempted, particularly for laparoscopic surgeries. However, cyanoacrylate-based glues leave brittle residues and have elevated toxicity when used on intra-abdominal tissues. Likewise, fibrin sealants do not provide immediate fixation between the mesh and tissues, and so in larger (>3 cm) hernia defects, additional mechanical devices such as sutures are needed to prevent edge curling and mesh slippage. To address these shortcomings, we propose to evaluate the combined application of two patented Clemson University technologies: a bifunctional poloxamine hydrogel adhesive and a surface modification technique to improve the adhesive strength between the hydrogel adhesive and polymer surgical meshes. The proposed hydrogel adhesive is non-toxic to cells in culture over a 12-day degradation period. It is biocompatible and safe as a tissue adhesive for treatment of small soft tissue wounds, eliciting a controlled inflammatory response in vivo without provoking unwanted tissue adhesions when used on intra-abdominal tissues. Although it exhibits an adhesive strength exceeding 70 kPa between tissues via mechanical interdigitation and covalent bond formation with tissue amines, the adhesive strength when used on unmodified PP mesh is inadequate. Therefore, a patented surface modification technique will be employed to provide a poly-glycidyl methacrylate (PGMA) layer grafted to human serum albumin (HSA) to form a three-dimensional plastic albumin. In our initial tests of adhesive strengths for meshes attached to collagen sheets with the hydrogel adhesive, the modified PP mesh using PGMA/HSA grafting resulted in significantly improved adhesive strength compared to unmodified meshes. Further development of our mesh-adhesive system will enable grafting of autologous proteins derived from the patient?s own blood onto PP surgical mesh at the time of surgery, thereby avoiding the potential for immunological reactions to foreign proteins on the mesh surface. This approach ultimately provides a complete solution for suture-less large hernia defect repair with immediate mesh fixation using our hydrogel adhesive, which will limit post-operative complications and hernia recurrence as part of a simplified laparoscopic procedure.

Public Health Relevance

Development of a Novel Bio-Adhesive Mesh System for Abdominal Hernia Repair Project Narrative The proposed project will enable abdominal hernia repair surgery to be performed laparoscopically with no mechanical fixation, such as tacks or sutures, which are difficult to use and often cause substantial post- operative pain. Through the use of both a patented, biocompatible tissue adhesive and a patented polymer surface modification technology to be applied to existing surgical mesh products, improved adhesion of the hernia mesh to abdominal tissues can be achieved as part of a laparoscopically-compatible application system. This approach ultimately provides a complete solution for suture-less large hernia defect repair with immediate mesh fixation using our hydrogel adhesive, which will limit post-operative complications and hernia recurrence as part of a less-invasive surgical procedure.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41DK120168-01
Application #
9680823
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Densmore, Christine L
Project Start
2019-09-15
Project End
2020-08-31
Budget Start
2019-09-15
Budget End
2020-08-31
Support Year
1
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Circa Bioscience, LLC
Department
Type
DUNS #
964241173
City
Greenwood
State
SC
Country
United States
Zip Code
29649